Showing results (971-980 of 3,003) with videos related to

Sort By:
Pageof 301
Clinical Kidney Journal|September 29, 2015
A peer outreach initiative to increase the registration of minorities as organ donorsJez Buffin, Robert Little, Neerja Jain, et al.
Clinical Kidney Journal|September 29, 2015
Thrombotic microangiopathy associated with proteasome inhibitorsAhad Lodhi, Abhishek Kumar, Muhammad U Saqlain, et al.
Clinical Kidney Journal|October 29, 2014
Renal replacement therapy in Latin American end-stage renal diseaseGuillermo Rosa-Diez, Maria Gonzalez-Bedat, Roberto Pecoits-Filho, et al.
Clinical Kidney Journal|December 16, 2014
Once-monthly continuous erythropoietin receptor activator (CERA) for haemoglobin maintenance in haemodialysis patients with chronic renal anaemiaNeval Duman, Abdullah Uyanik, Abdulkadir Unsal, et al.
Clinical Kidney Journal|September 9, 2020
Incidence, risk factors and distribution of syphilis in the end-stage renal disease population in the USAErena N Weathers, Jennifer L Waller, N Stanley Nahman, et al.
Clinical Kidney Journal|September 9, 2020
Proteomic characterization of obesity-related nephropathyRalph Wendt, Tianlin He, Agnieszka Latosinska, et al.
Clinical Kidney Journal|September 9, 2020
Prognosis and long-term outcomes of acute kidney injury due to snake envenomationP S Priyamvada, Challa Jaswanth, Bobby Zachariah, et al.
Clinical Kidney Journal|September 9, 2020
Erratum: The potential for improving cardio-renal outcomes by sodium-glucose co-transporter-2 inhibition in people with chronic kidney disease: a rationale for the EMPA-KIDNEY studyWilliam G Herrington, David Preiss, Richard Haynes, et al.
Clinical Kidney Journal|September 9, 2020
Machine learning analysis of serum biomarkers for cardiovascular risk assessment in chronic kidney diseaseCarles Forné, Serafi Cambray, Marcelino Bermudez-Lopez, et al.
Clinical Kidney Journal|September 8, 2020
The growing pains of ifosfamideBen Sprangers, Sebastian Lapman
Pageof 301